Predictive And Prognostic Value Of Systemic Inflammatory Response Biomarkers In Patients Receiving Nivolumab For Metastatic Non-Small Cell Lung Cancer (Nsclc).

JOURNAL OF CLINICAL ONCOLOGY(2017)

引用 4|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要